This innovative new post will be a critical part of the multidisciplinary team that will support the ongoing development of the breast cancer disease group at one of the leading Cancer Centres in Europe.
Breast cancer is the largest and one of the busiest services at the Trust.
Pharmacy supports a rapidly-growing portfolio of systemic anti-cancer therapies (SACT) across a comprehensive network, allowing the Trust to administer parenteral SACT in 11 outreach and peripheral satellites and at patients’ homes as well as the Christie hospital main site.
In addition, there has been a huge growth in oral SACT in recent years, following an increase in positive Technology Appraisals published by NICE. The clinical pharmacy team has grown in response with the appointment of additional clinical pharmacist prescribers, but now needs senior strategic leadership to develop the service further.
Applicants who have started, but not yet completed the Royal Pharmaceutical Society (RPS) consultant pharmacist credentialling process and who can demonstrate significant progress towards approval may be considered for appointment to an interim non-consultant developmental role pending completion of RPS credentialling.
The postholder will provide strategic leadership for a high-quality professional clinical pharmacy team supporting breast cancer services, optimising access to medicines and improving the overall patient experience.
The post holder will work in collaboration with the breast cancer disease group, the Trust’s network services division, multidisciplinary clinical and researcher colleagues, and the Trust’s designated commercial and outsourced service providers to develop and deliver an efficient, high quality, professional and well-coordinated service capable of meeting patients’ clinical needs and all statutory, regulatory and NHS commissioning requirements relating to cancer services.
This will include provision of direct patient care to patients, as a non-medical prescriber with their own clinic caseload as agreed with the breast cancer clinical lead.
The Christie is one of Europe’s leading cancer centres, treating over 60,000 patients a year. We are based in Manchester and serve a population of 3.2 million across Greater Manchester & Cheshire, but as a national specialist around 15% patients are referred to us from other parts of the country.
We provide radiotherapy through one of the largest radiotherapy departments in the world; chemotherapy on site and through 14 other hospitals; highly specialist surgery for complex and rare cancer; and a wide range of support and diagnostic services. We are also an international leader in research, with world first breakthroughs for over 100 years.
We run one of the largest early clinical trial units in Europe with over 300 trials every year. Cancer research in Manchester, most of which is undertaken on the Christie site, has been officially ranked the best in the UK.
For further details / informal visits contact: Name: Damian Child Job title: Director of Pharmacy Email address:
[email protected] Telephone number: 07929 065449
